Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Clinical trial

Septic cArdiac Deficiency and MenIngococcal seveRe Sepsis

ID
Name
AOR 10106
Description
Use of brain natriuretic peptide to evaluate the cardiac function in the course of meningococcal septic shock or severe sepsis.
Trial arms
Trial start
2012-03-05
Estimated PCD
2018-07-11
Trial end
2018-07-11
Status
Completed
Treatment
BNP
Repeated brain natriuretic peptide dosages and cardiac echographies up to day 5
Arms:
Population
Size
35
Primary endpoint
Repeated brain natriuretic peptide (BNP) blood level
Up to day 5
Eligibility criteria
Inclusion Criteria: * Children * 6 months to 18 years aged * without previous cardiac pathology * hospitalized in the participating pediatric intensive care units for serious sepsis with extensive purpura Exclusion Criteria: * Heart malformative disorder with right-left shunt * Pre-existent known cardiac insufficiency whatever is the origin * Concomitant participation in another trial * Patient in period of exclusion from another trial * Not membership in a national insurance scheme
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'NA', 'interventionModel': 'SINGLE_GROUP', 'primaryPurpose': 'DIAGNOSTIC', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 35, 'type': 'ACTUAL'}}
Updated at
2023-08-28

1 organization

1 product

3 indications

Organization
Assistance Publique - Hôpitaux de Paris
Product
BNP
Indication
Meningococcal Infections
Indication
Septic shock
Indication
Sepsis